Pulse Biosciences, Inc. (PLSE) Operating cash flow 2016–2025
Pulse Biosciences, Inc. (PLSE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$54.1MFY2025 · since FY2016: -$8.1M → -$54.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.1M | -48.9% |
| FY2024 | -$36.3M | -10.0% |
| FY2023 | -$33.0M | +29.7% |
| FY2022 | -$47.0M | +13.1% |
| FY2021 | -$54.1M | -53.0% |
| FY2020 | -$35.4M | -3.5% |
| FY2019 | -$34.2M | -43.1% |
| FY2018 | -$23.9M | -115.5% |
| FY2017 | -$11.1M | -37.7% |
| FY2016 | -$8.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net incomePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating incomePLSE Operating marginPLSE Free cash flowPLSE Capital expendituresPLSE Return on equityPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Total liabilitiesPLSE Shareholders’ equityPLSE overview →